I've followed Diacrin closely for several years. They always seemed like a very cool company.The news on The parkinsons trial data announced in qtr 3 could be huge ,but the stock could have an extreme reaction to this news. It will be very interesting to watch this play out.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat